The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health care resource utilization in patients with advanced melanoma receiving immunotherapies in the real world.
 
Richard Wayne Joseph
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Exelixis; Genoptix; Merck (Inst); Nektar; Novartis
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Merck; Roche/Genentech (Inst); X4 Pharma (Inst)
 
Alicia C. Shillington
Research Funding - Bristol-Myers Squibb (Inst); Janssen Scientific Affairs (Inst); Kite, a Gilead company (Inst); Merck (Inst); United Therapeutics (Inst)
 
Todd Lee
No Relationships to Disclose
 
Cynthia Macahilig
Research Funding - Bristol-Myers Squibb; Kite, a Gilead company; Merck
 
Scott J. Diede
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Vaidehi Dave
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Regeneron (Inst); Sanofi (Inst); Seagen (Inst); United Therapeutics (Inst)
 
Qing Harshaw
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst)
 
Emilie Taymor
Employment - Merck
Stock and Other Ownership Interests - Gilead Sciences (I); Merck
 
Frank Xiaoqing Liu
Employment - Merck
Stock and Other Ownership Interests - Merck